Alyeska Investment Group
AUPH icon

Alyeska Investment Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Alyeska Investment Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-188,709
Closed -$1.06M – 408
2018
Q2 		$1.06M Sell
188,709
-387,615
-67% -$2.16M 0.01% 394
2018
Q1 		$2.99M Sell
576,324
-5,193
-0.9% -$27.8K 0.03% 323
2017
Q4 		$2.63M Sell
581,517
-100,000
-15% -$555K 0.02% 312
2017
Q3 		$4.27M Buy
681,517
+12,171
+2% +$76.7K 0.03% 303
2017
Q2 		$4.1M Sell
669,346
-120,846
-15% -$814K 0.04% 295
2017
Q1 		$5.8M Buy
+790,192
New +$3.65M 0.05% 299

Other funds holding AUPH

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return